8EC.F - Empower Clinics Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.0220
-0.0030 (-12.00%)
At close: 8:05AM CET
Stock chart is not supported by your current browser
Previous Close0.0250
Open0.0220
Bid0.0220 x 0
Ask0.0406 x 0
Day's Range0.0220 - 0.0220
52 Week Range0.0210 - 0.1510
Volume91,950
Avg. Volume23,706
Market Cap3.226M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0160
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Empower Clinics Reports Q3 2019 Results Highlighted by a 137% increase in clinic revenues compared to Q3 2018

    Net loss of $504,531, compared to $378,657 for Q3 2018, which was primarily driven by increased revenues and fair value adjustments offset by net increased in operating expenses related to the operations of Sun Valley. Cash at September 30, 2019 of $178,578, compared to $157,668 at December 31, 2018, which was primarily driven by debt and equity financings during the nine months ended September 30, 2019 and partially offset by cash used in operations, the cash investment in Sun Valley and cash investment in Sun Valley Health Franchise launch. Strategic redirection: The Company has been re-positioning its overall strategy to become a vertically integrated health and wellness brand that connects to its 165,000 patients using a data driven focus to improve patients' lives with products, technology and health systems.

  • CNW Group

    Empower Clinics Announces Record Preliminary Unaudited Q3 2019 Revenue with 138% year over year increase and Details for Release of Financial Statements

    Company's Q3 preliminary total direct clinic expenses have been reduced by approximately 40% even with the addition of the six Sun Valley clinic locations. VANCOUVER, Nov. 7, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (OTC:EPWCF - News) (Frankfurt 8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction facility in Oregon, is pleased to announce preliminary unaudited year over year revenue growth of 138% for the three months ended September 30, 2019. The company also decreased total direct clinic expenses by approximately 40%, while adding six new clinics as a result of the Sun Valley clinics acquisition.

  • CNW Group

    Empower Clinics Provides Corporate Updates Highlighting Triple Digit Patient Growth and Subsidiary Sun Valley Health Launches New Modalities and Patient Services

    VANCOUVER, Oct. 10, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (OTC:EPWCF - News) (Frankfurt 8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction facility in Oregon, is pleased to announce it is launching seven new modalities and services for patients in the Sun Valley Health clinics commencing Monday October 14th, 2019. The Company also has patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 versus September 2018 with 614 patients seen. "The tremendous year-over-year increase in patient visits is a testament to the operating strengths and patient management demonstrated by our clinic team members, each and every day," said Steven McAuley, CEO of Empower.

  • CNW Group

    Empower Clinics to Begin Trading on OTCQB on August 20th, 2019 Under Ticker Symbol (OTC: EPWCF)

    VANCOUVER, Aug. 20, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (Frankfurt: 8EC) (OTC:EPWCF - News) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., today announced that its common shares will begin trading on the OTCQB Venture Market at the opening of the market on August 20th, 2019 under the stock symbol (OTC:EPWCF - News). Investors can find Real-Time quotes and market information for the company on http://www.otcmarkets.com.

  • CNW Group

    Empower Clinics Reports 2Q 2019 Results Highlighted by an 89% increase in clinic revenues and a 37% decrease in operating expenses compared to 2Q 2018

    VANCOUVER, Aug. 14, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (Frankfurt 8EC) (OTC:EPWCF - News) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., has filed today its unaudited interim condensed consolidated financial statements for the three and six months ended June 30th, 2019 and related management's discussion and analysis, both of which are available at www.SEDAR.com. "The impact of cost cutting measures and the benefit of the Sun Valley acquisition are now showing up in the financial statements of the Company" said Steven McAuley, Empower's Chairman & CEO.

  • CNW Group

    Empower Clinics Receives Approval from SQUARE to Process CBD Product Sales in Clinics, Stores, Online, and throughout the Company Network Nationwide in the U.S.

    VANCOUVER, Aug. 12, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (Frankfurt 8EC) (OTC:EPWCF - News) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., is pleased to announce it has received approval from SQUARE, Inc. to accept card payments from customers that want to purchase CBD products and other wellness products from the Company in clinics, stores and online. Patients and customers can now purchase hemp-derived CBD products and diverse wellness products from Empower Clinics & Sun Valley Health online and in-store using the SQUARE payment processing system, ensuring ease-of-use and a positive checkout experience.

  • Empower Clinics Enters Into Strategic Partnership With Heritage Cannabis Subsidiary Endocanna Health to Create and Sell Endocannabinoid DNA Test Products
    CNW Group

    Empower Clinics Enters Into Strategic Partnership With Heritage Cannabis Subsidiary Endocanna Health to Create and Sell Endocannabinoid DNA Test Products

    Endocanna will manufacture its patent-pending Endocannabinoid DNA Test Kits for and license its proprietary DNA technology to Empower. The Company plans to include the DNA Test Kits as a standard offering in the Sun Valley Health franchise program, and has commenced it's roll-out in the United States.

  • CNW Group

    Empower Announces Filing of Amended Business Acquistion Report

    VANCOUVER , July 17, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (" Empower " or the " Company ") today announced that it has filed an amended business ...

  • CNW Group

    Empower Clinics Provides Corporate Update to Announce First Franchise Application and Sun Valley BAR Filing

    VANCOUVER, July 17, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (Frankfurt 8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to announce it has received it's first signed franchise application and that the Company has filed on sedar.com, the Business Acquisition Report (BAR) for the Sun Valley Certification Clinics Holdings LLC acquisition. The Company continues to reach a number of important milestones on its path forward, as a global health and wellness company, serving the needs of patients through its network of physician-staffed health and pain management clinics, formulating CBD based products and developing its first CBD extraction facility.

  • CNW Group

    Empower Clinics Commences Selling Franchises Under The Sun Valley Health Brand

    VANCOUVER, July 8, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:CBDT.CN - News) (Frankfurt 8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to announce that the Company's clinic division, Sun Valley Health, has completed it's 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States. With the completion of the 2019 Franchise Disclosure Document (FDD) the Company is now selling Sun Valley Health franchises and is accepting franchise applications effectively immediately. The Company has invested in the development of a new franchise trade show booth that showcases the Sun Valley Health opportunity to perspective franchisees using dynamic, content rich displays and four (4) large format television monitors to present features and benefits to the audience who attend the expos.

  • CNW Group

    Cannvas Provides Corporate Update on Strategic Initiatives

    TORONTO, June 26, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE:MTEC.CN - News) (Frankfurt: 3CM) (OTCPK:CANVF - News), a global digital cannabis education and analytics company, is pleased to announce significant growth in the digital traffic to its cannabis education platform Cannvas.Me, an unbiased evidence-based cannabis education resource providing physician-backed and educator-approved cannabis learning on all aspects of the plant with no pressure to purchase or consume. Cannvas is also pleased to share recent company updates across a series of initiatives and strategic partnerships. In April, Cannvas announced a definitive partnership with Seed Technology, a California-based interactive customer-focused cannabis education platform, granting Cannvas exclusive Canadian rights to distribute co-branded kiosks and related technology to medical clinics and retailers across Canada.

  • CNW Group

    Cannvas Enters European Markets Following Successful Entry into U.S. Cannabis Market

    TORONTO, May 15, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE:MTEC.CN - News) (Frankfurt: 3CM) (OTCPK:CANVF - News), a leading digital cannabis education and analytics company, is pleased to announce it has undertaken expansion plans across the European market, implementing a similar revenue growth strategy to the one it successfully followed to enter the U.S. space. "The Cannvas executive team has spent a significant amount of time in Europe advancing the need for cannabis education directed at consumers and health care practitioners coupled with analytics to better understand a rapidly-growing cannabis market across the continent," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech.

  • Empower Amends Terms of Debenture Offering and Announces Non-Brokered Private Placement of Units
    CNW Group

    Empower Amends Terms of Debenture Offering and Announces Non-Brokered Private Placement of Units

    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER , March 22, 2019 /CNW/ - EMPOWER CLINICS INC.  (CSE: EPW) (Frankfurt 8EC) (" Empower ...

  • CNW Group

    Empower Announces Updates to AI Pilot Program

    VANCOUVER, March 19, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt: 8EC) ("Empower" or the "Company"), a growth oriented and diversified medical cannabis company, is pleased to provide an update on recent activities by the technical teams at Empower and Canntop AI Inc. ("Canntop"), a subsidiary of Datametrex AI Limited ("Datametrex") to develop a deeper understanding of patient awareness of cannabis-based treatment options and ongoing effectiveness of treatment programs.

  • Empower Clinics Announces Private Placement of Convertible Debentures
    CNW Group

    Empower Clinics Announces Private Placement of Convertible Debentures

    VANCOUVER, March 4, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company") today announces it will be conducting a non-brokered private placement (the "Financing") of unsecured convertible debentures (each, a "Debenture") in the aggregate principal amount of up to $1,500,000. Each Debenture will be convertible into units of the Company (each, a "Unit") at a conversion price of $0.15 per Unit, with each Unit to consist of one common share in the capital of the Company (each, a "Share") and one non-transferable share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder to purchase one Share at a price of $0.20 per Share for a period of two years from the closing of the Financing (the "Closing"), subject to acceleration in the event that the closing price of the Shares on the Canadian Securities Exchange (the "CSE"), or such other stock exchange as the Shares are then principally traded, is greater than $0.40 per Share for at least 10 consecutive trading days.

  • Empower Announces Intent to Open CBD Extraction Facility
    CNW Group

    Empower Announces Intent to Open CBD Extraction Facility

    VANCOUVER, Feb. 28, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company") today announces it intends to open a fully functioning hemp-based CBD extraction facility in greater Portland, Oregon in Q2 2019 with the first extraction system expected to have the capacity to produce 6,000 kg of extracted product per year. Aibeida's director and Chief Scientist, Dr. Shuang Xie, PhD., in Canada will oversee and manage the Empower CBD extraction facility, which is expected to provide Empower with vertical integration into the CBD supply chain, producing isolates, distillates and crude oil that have shown successful third party test results in the initial test facility. "Achieving vertical integration has been an objective of mine from the outset as we attempt to connect the science behind hemp-derived CBD based therapies and the efficacy of physician recommended treatment options made available through our clinic network, online or through retail partnerships," stated Steven McAuley, CEO of Empower.

  • Empower Announces AI Pilot Program
    CNW Group

    Empower Announces AI Pilot Program

    VANCOUVER, Feb. 5, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company") today announces it intends to partner with Datametrex AI Limited ("Datametrex") and its subsidiary, Canntop AI Inc. ("Canntop"), to create a pilot program that uses Artificial Intelligence (AI) to analyze and gain insights about Empower patient data, physician treatment recommendations and overall long-term efficacy of patient care. The pilot program is expected to utilize Empower patient data in a HIPAA compliant manner, to determine if normalized data can be generated using Datametrex AI solutions to understand how patient care and efficacy of physician-guided treatment recommendations are positively impacting serious qualifying conditions of patients.

  • Empower Clinics Announces Major Acquisition
    CNW Group

    Empower Clinics Announces Major Acquisition

    VANCOUVER, Jan. 28, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company") today announces it has entered into a non-binding term sheet to acquire the business of Sun Valley Certification Clinics Holdings LLC ("Sun Valley"), including its interests in certain affiliates thereof, by way of a share or asset acquisition, subject to due diligence and customary closing conditions. Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry, which is believed to be the first of its kind in the United States. The proposed transaction is expected to create one of the largest clinic groups in the medical cannabis sector in the United States, with twelve physical locations having a combined patient count of 165,000 patients in Washington, Oregon, Illinois, Arizona, Nevada and California, and the potential to rapidly expand the clinic network via the Sun Valley franchise program.

  • Empower Clinics Provides Corporate Update
    CNW Group

    Empower Clinics Provides Corporate Update

    SEATTLE, WA, Jan. 17, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company") today provided a corporate update on operations and changes to its board of directors. The Company is pleased to announce its first production run of Sollievo CBD lotion has commenced selling in two test markets - Portland, OR and Seattle, WA.